Roche discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals – from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
Roche needed to comply with Or728a, a Swiss legislated regulation on internal control. Roche also wanted to improve its financial reporting on internal control.
BWise was chosen because of the high quality software, global presence and company size and health. Roche eventually implemented BWise in 26 countries, including the United States, France, Switzerland and Japan.